Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (114564) 114564
Newspaper Article (17141) 17141
Newsletter (11475) 11475
Publication (8694) 8694
Trade Publication Article (852) 852
Book Review (706) 706
Magazine Article (607) 607
Book Chapter (537) 537
Web Resource (305) 305
Dissertation (246) 246
Conference Proceeding (238) 238
Government Document (184) 184
Book / eBook (122) 122
Transcript (82) 82
Reference (30) 30
Report (13) 13
Data Set (8) 8
Streaming Video (5) 5
Journal / eJournal (4) 4
Paper (4) 4
Presentation (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79401) 79401
female (73561) 73561
ovarian cancer (70864) 70864
oncology (41520) 41520
index medicus (39945) 39945
cancer (37848) 37848
middle aged (26255) 26255
ovarian neoplasms - pathology (26131) 26131
adult (25304) 25304
research (21961) 21961
aged (19249) 19249
chemotherapy (17853) 17853
animals (16873) 16873
tumors (16378) 16378
ovarian-cancer (16106) 16106
obstetrics & gynecology (14711) 14711
prognosis (12740) 12740
care and treatment (12582) 12582
expression (12045) 12045
carcinoma (11793) 11793
ovarian neoplasms - drug therapy (11721) 11721
cell line, tumor (11573) 11573
ovarian neoplasms - genetics (11323) 11323
breast cancer (11198) 11198
health aspects (10915) 10915
metastasis (10668) 10668
male (10632) 10632
oncology, experimental (10239) 10239
mice (9943) 9943
genetic aspects (9931) 9931
ovarian neoplasms - metabolism (9892) 9892
apoptosis (9658) 9658
analysis (9554) 9554
cancer therapies (8384) 8384
women (8145) 8145
breast-cancer (8076) 8076
proteins (7792) 7792
gene expression (7772) 7772
ovarian neoplasms - surgery (7752) 7752
immunohistochemistry (7597) 7597
surgery (7504) 7504
mutation (7479) 7479
ovarian neoplasms - diagnosis (7417) 7417
neoplasm staging (7412) 7412
diagnosis (7288) 7288
survival (6778) 6778
pathology (6746) 6746
aged, 80 and over (6689) 6689
cell biology (6620) 6620
medical research (6400) 6400
womens health (6106) 6106
development and progression (6059) 6059
adolescent (5993) 5993
risk factors (5979) 5979
biochemistry & molecular biology (5785) 5785
retrospective studies (5317) 5317
article (5268) 5268
reports (5218) 5218
studies (5149) 5149
cisplatin (5132) 5132
clinical trials (5014) 5014
tumor cells, cultured (5008) 5008
ovarian carcinoma (4969) 4969
ovarian neoplasms (4861) 4861
medicine (4815) 4815
patients (4806) 4806
ovarian neoplasms - therapy (4780) 4780
cells (4773) 4773
treatment outcome (4757) 4757
medicine & public health (4582) 4582
genes (4508) 4508
gene expression regulation, neoplastic (4500) 4500
ovary (4479) 4479
medical prognosis (4467) 4467
ovarian neoplasms - mortality (4411) 4411
obstetrics and gynecology (4294) 4294
antineoplastic agents - pharmacology (4271) 4271
antineoplastic combined chemotherapy protocols - therapeutic use (4268) 4268
pregnancy (4135) 4135
research article (4082) 4082
pharmacology & pharmacy (4070) 4070
medicine, research & experimental (4063) 4063
hematology, oncology and palliative medicine (3974) 3974
biomarkers (3867) 3867
breast neoplasms - genetics (3860) 3860
drug therapy (3768) 3768
genetics & heredity (3730) 3730
growth (3689) 3689
risk (3675) 3675
immunotherapy (3655) 3655
kinases (3641) 3641
antineoplastic agents - therapeutic use (3618) 3618
cell proliferation (3599) 3599
therapy (3586) 3586
diagnosis, differential (3544) 3544
young adult (3499) 3499
paclitaxel (3496) 3496
signal transduction (3487) 3487
mice, nude (3422) 3422
gynecology (3391) 3391
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (64) 64
Online Resources - Online (16) 16
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
St. Michael's Hospital - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Lakeridge Health Sciences - Online (1) 1
Media Commons - Audio Visual (1) 1
OISE - Stacks (1) 1
Regis College - Circulation Desk (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (137147) 137147
French (1542) 1542
German (1403) 1403
Chinese (1287) 1287
Japanese (1174) 1174
Russian (982) 982
Polish (536) 536
Korean (439) 439
Spanish (425) 425
Italian (324) 324
Czech (191) 191
Portuguese (116) 116
Bulgarian (110) 110
Hungarian (90) 90
Dutch (59) 59
Danish (53) 53
Croatian (50) 50
Serbian (37) 37
Turkish (32) 32
Ukrainian (32) 32
Romanian (27) 27
Norwegian (25) 25
Hebrew (22) 22
Swedish (16) 16
Finnish (14) 14
Slovak (12) 12
Arabic (11) 11
Persian (11) 11
Slovenian (5) 5
Lithuanian (4) 4
Catalan (2) 2
Greek (2) 2
Hindi (2) 2
Icelandic (2) 2
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ovarian serous tumors of low malignant potential (borderline tumors): Outcome-based study of 276 patients with long-term (≥5-year) follow-up
by Longacre, Teri A and McKenney, Jesse K and Tazelaar, Henry D and Kempson, Richard L and Hendrickson, Michael R
American Journal of Surgical Pathology, ISSN 0147-5185, 06/2005, Volume 29, Issue 6, pp. 707 - 723
The natural history, classification, and nomenclature of ovarian serous tumors of low malignant potential (S-LMP) (serous tumors of borderline malignancy,... 
Micro-invasion | Atypical proliferating tumor | Borderline tumor | Invasive implant | Micropapillary | Serous tumor of low malignant potential | microinvasion | PERITONEAL IMPLANTS | SURGERY | micropapillary | INVOLVEMENT | serous tumor of low malignant potential | HISTOLOGIC FEATURES | PATHOLOGY | EPITHELIAL TUMORS | GRADE CARCINOMA | atypical proliferating tumor | CRIBRIFORM PATTERNS | RECURRENCE | DIAGNOSTIC-CRITERIA | borderline tumor | invasive implant | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - pathology | Disease Progression | Neoplasm Metastasis | Cell Transformation, Neoplastic | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Neoplasm Staging | Child
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text VEGF-A modulates expression of inhibitory checkpoints on CD8+ + T cells in tumors
by Voron, Thibault and Colussi, Orianne and Marcheteau, Elie and Pernot, Simon and Nizard, Mevyn and Pointet, Anne-Laure and Latreche, Sabrina and Bergaya, Sonia and Benhamouda, Nadine and Tanchot, Corinne and Stockmann, Christian and Combe, Pierre and Berger, Anne and Zinzindohoue, Franck and Yagita, Hideo and Tartour, Eric and Taieb, Julien and Terme, Magali
Journal of Experimental Medicine, ISSN 0022-1007, 2015, Volume 212, Issue 2, pp. 139 - 148
Immune escape is a prerequisite for tumor development. To avoid the immune system, tumors develop different mechanisms, including T cell exhaustion, which is... 
CANCER PATIENTS | MEDICINE, RESEARCH & EXPERIMENTAL | CARCINOMA PATIENTS | DIRECTLY SUPPRESSES ACTIVATION | IMMUNE SUPPRESSION | TYROSINE KINASE INHIBITOR | RECEPTOR-TYPE 2 | OVARIAN-CANCER | IMMUNOLOGY | CHRONIC VIRAL-INFECTION | EXHAUSTION | ENDOTHELIAL GROWTH-FACTOR | Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Gene Expression Profiling | Vascular Endothelial Growth Factor A - metabolism | Receptors, Vascular Endothelial Growth Factor - metabolism | Neoplasms - genetics | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Vascular Endothelial Growth Factor A - pharmacology | Disease Models, Animal | CTLA-4 Antigen - metabolism | Programmed Cell Death 1 Receptor - metabolism | CTLA-4 Antigen - genetics | Lymphocytes, Tumor-Infiltrating - drug effects | Animals | Signal Transduction - drug effects | Neoplasms - immunology | CD8-Positive T-Lymphocytes - drug effects | Protein Binding | Mice | CD8-Positive T-Lymphocytes - immunology | Neoplasms - pathology | Programmed Cell Death 1 Receptor - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Brief Definitive Report
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Inactivation of tumor‐specific CD8+ CTLs by tumor‐infiltrating tolerogenic dendritic cells
by Harimoto, Hirotomo and Shimizu, Masumi and Nakagawa, Yohko and Nakatsuka, Katsuhisa and Wakabayashi, Ayako and Sakamoto, Choitsu and Takahashi, Hidemi
Immunology and Cell Biology, ISSN 0818-9641, 10/2013, Volume 91, Issue 9, pp. 545 - 555
Cancer immunosurveillance failure is largely attributed to the insufficient activation of tumor‐specific class I major histocompatibility complex (MHC)... 
tumor‐infiltrating lymphocytes | CTL | tumor‐infiltrating dendritic cells | Hepa1‐6 | costimulatory molecule | tumor-infiltrating lymphocytes | tumor-infiltrating dendritic cells | Hepa1-6 | ACTIVATION | HIV GAG PROTEIN | MECHANISM | INDUCTION | IMMUNOLOGY | CYTOTOXIC T-LYMPHOCYTES | ANTIGENIC PEPTIDE | CELL BIOLOGY | DEC-205 RECEPTOR | IN-VIVO | INFECTION | OVARIAN-CANCER PROGRESSION | Neoplasm Transplantation | Tumor Escape | Minor Histocompatibility Antigens | Dendritic Cells - immunology | Transforming Growth Factor beta1 - metabolism | Gene Expression Regulation, Neoplastic | Vascular Endothelial Growth Factor A - metabolism | Antigens, CD - metabolism | CD11c Antigen - metabolism | Lectins, C-Type - metabolism | Carcinoma, Hepatocellular - immunology | Cell Differentiation | alpha-Fetoproteins - metabolism | Antigens, Neoplasm - immunology | Lymphocyte Activation | Mice, Inbred C57BL | Immune Tolerance | Receptors, Cell Surface - metabolism | Tumor Burden | Immunosuppression | Intercellular Adhesion Molecule-1 - metabolism | Animals | Intercellular Adhesion Molecule-1 - genetics | Cell Line, Tumor | Cross-Priming | Mice | CD8-Positive T-Lymphocytes - immunology | Cell Movement | Cytotoxicity, Immunologic | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Tumor–platelet interaction in solid tumors
by Buergy, Daniel and Wenz, Frederik and Groden, Christoph and Brockmann, Marc A
International Journal of Cancer, ISSN 0020-7136, 06/2012, Volume 130, Issue 12, pp. 2747 - 2760
Elevated platelet counts in patients diagnosed with malignant tumors were first described more than 100 years ago. Today it is well known that in many types of... 
thrombocytosis | cancer | metastasis | angiogenesis | platelets | GYNECOLOGIC-ONCOLOGY-GROUP | HEMATOPOIETIC STEM-CELL | LEUKEMIA INHIBITORY FACTOR | MPL-DEFICIENT MICE | RENAL-CELL CARCINOMA | EPITHELIAL OVARIAN-CARCINOMA | METASTATIC MALIGNANT-MELANOMA | LUNG-CANCER | COLORECTAL-CANCER PATIENTS | ONCOLOGY | ENDOTHELIAL GROWTH-FACTOR | Blood Platelets - pathology | Neoplasm Metastasis | Neoplasms - blood | Platelet Count | Humans | Neovascularization, Pathologic | Neoplasms - blood supply | Neoplasms - pathology | Survival | Thrombocytosis - pathology | Medical prognosis | Rodents | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Tumor immune surveillance and ovarian cancer
: Lessons on immune mediated tumor rejection or tolerance
by Kandalaft, Lana E and Motz, Gregory T and Duraiswamy, Jaikumar and Coukos, George
Cancer and Metastasis Reviews, ISSN 0167-7659, 3/2011, Volume 30, Issue 1, pp. 141 - 151
In the past few years, cancer immunotherapies have produced promising results. Although traditionally considered unresponsive to immune therapy, increasing... 
Oncology | Cancer Research | Tumor immunoserveillance | Biomedicine | Biomedicine general | Ovarian cancer | CARCINOMA-CELLS | ENDOTHELIN-B RECEPTOR | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | DENDRITIC CELLS | PROGRAMMED DEATH-1 | INFILTRATING LYMPHOCYTES | INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION | ONCOLOGY | RECOMBINANT INTERFERON-GAMMA | IN-VIVO | REGULATORY T-CELLS | Antigens, CD - immunology | Apoptosis Regulatory Proteins - immunology | Tumor Escape | Endothelial Cells - metabolism | Humans | Immune Tolerance | Indoleamine-Pyrrole 2,3,-Dioxygenase - immunology | Immunologic Surveillance - immunology | Endothelial Cells - immunology | Tumor Microenvironment - immunology | Signal Transduction - immunology | Animals | Female | Programmed Cell Death 1 Receptor | Ovarian Neoplasms - immunology | Care and treatment | Immunotherapy | Oncology, Experimental | Development and progression | Research | Vascular endothelial growth factor | Cancer | Endothelium | Endothelin | Immune response | Effector cells | Data processing | Immunosurveillance | Immunological tolerance | Survival | Metastases | Angiogenesis | Reviews | Immunogenicity | Antitumor activity | Microenvironments | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Ovarian tumors
by Geist, Samuel Herbert, 1885
1942, xi p., 1 l., 527 p. illus.
Ovaries | Tumors
Book
Details down arrow
7. Full Text SMARCA4 (BRG1) Loss of Expression Is a Useful Marker for the Diagnosis of Ovarian Small Cell Carcinoma of the Hypercalcemic Type (Ovarian Rhabdoid Tumor): A Comprehensive Analysis of 116 Rare Gynecologic Tumors, 9 Soft Tissue Tumors, and 9 Melanomas
by Karanian-Philippe, Marie and Velasco, Valérie and Longy, Michel and Floquet, Anne and Arnould, Laurent and Coindre, Jean-Michel and Le Naoures-Méar, Cécile and Averous, Gerlinde and Guyon, Frédéric and MacGrogan, Gaëtan and Croce, Sabrina
The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2015, Volume 39, Issue 9, pp. 1197 - 1205
Ovarian small cell carcinoma of the hypercalcemic type (SCCOHT)/ovarian rhabdoid tumor is a rare and highly malignant tumor that typically occurs in young... 
Rhabdoid tumor | Ovary | INI1/SMARCB1 | SMARCA4/BRG1 | Small cell carcinoma hypercalcemic type | SURGERY | SMARCB1 | FUSION | NEOPLASMS | BRG1 | PATHOLOGY | small cell carcinoma hypercalcemic type | SMARCA4 | INI1 | ovary | SARCOMAS | rhabdoid tumor | MUTATIONS | Immunohistochemistry | Predictive Value of Tests | Carcinoma, Small Cell - genetics | Nuclear Proteins - analysis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Sarcoma, Ewing - pathology | Granulosa Cell Tumor - pathology | Rhabdoid Tumor - pathology | Bone Neoplasms - pathology | Ovarian Neoplasms - genetics | Young Adult | Carcinoma, Small Cell - chemistry | Sarcoma, Endometrial Stromal - pathology | Soft Tissue Neoplasms - chemistry | Melanoma - genetics | Bone Neoplasms - chemistry | Adult | Female | Bone Neoplasms - genetics | Melanoma - chemistry | Soft Tissue Neoplasms - genetics | Hypercalcemia - genetics | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Sarcoma, Ewing - chemistry | Hypercalcemia - pathology | Endometrial Neoplasms - chemistry | Biomarkers, Tumor - analysis | Rhabdoid Tumor - chemistry | Hypercalcemia - metabolism | Melanoma - pathology | Sarcoma, Endometrial Stromal - chemistry | Rhabdoid Tumor - genetics | Biopsy | Adolescent | Soft Tissue Neoplasms - pathology | DNA Helicases - analysis | Endometrial Neoplasms - pathology | Granulosa Cell Tumor - chemistry | Biomarkers, Tumor - genetics | Transcription Factors - analysis | Carcinoma, Small Cell - pathology | Neoplasm Staging | Sarcoma, Ewing - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Tumor Evasion of the Immune System by Converting CD4+CD25- T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-beta
by Liu, Victoria C and Wong, Larry Y and Jang, Thomas and Shah, Ali H and Park, Irwin and Yang, Ximing and Zhang, Qiang and Lonning, Scott and Teicher, Beverly A and Lee, Chung
The Journal of Immunology, ISSN 0022-1767, 03/2007, Volume 178, Issue 5, pp. 2883 - 2892
CD4(+)CD25(+) T regulatory (T-reg) cells were initially described for their ability to suppress autoimmune diseases in animal models. An emerging interest is... 
INTESTINAL INFLAMMATION | LUNG-CANCER | GROWTH-FACTOR-BETA | DENDRITIC CELLS | AUTOIMMUNITY | TRANSCRIPTION FACTOR FOXP3 | IMMUNOLOGICAL SELF-TOLERANCE | PERIPHERAL-BLOOD | OVARIAN-CANCER | IMMUNOLOGY | LYMPHOCYTES | Transforming Growth Factor beta - immunology | Tumor Escape | Neoplasm Proteins - immunology | Male | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Culture Media, Conditioned | Animals | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Cytokines - immunology | Interleukin-2 Receptor alpha Subunit - immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases
by Vang, Russell and Hannibal, Charlotte G and Junge, Jette and Frederiksen, Kirsten and Kjaer, Susanne K and Kurman, Robert J
The American Journal of Surgical Pathology, ISSN 0147-5185, 02/2017, Volume 41, Issue 6, pp. 725 - 737
Ovarian serous borderline tumors (SBTs) have been the subject of considerable controversy, particularly with regard to terminology and behavior. It has been... 
micropapillary variant | SURVIVAL | SURGERY | POPULATION | MICROPAPILLARY PATTERN | PROGNOSIS | serous tumor of low malignant potential | FOLLOW-UP | serous borderline tumor | PATHOLOGY | noninvasive low-grade serous carcinoma | LYMPH-NODE INVOLVEMENT | OVARIAN-TUMORS | noninvasive micropapillary serous carcinoma | CRIBRIFORM PATTERNS | RECURRENCE | DIAGNOSTIC-CRITERIA | atypical proliferative serous tumor | Prognosis | Follow-Up Studies | Neoplasm Invasiveness | Humans | Middle Aged | Ovarian Neoplasms - pathology | Proportional Hazards Models | Ovarian Neoplasms - mortality | Cystadenocarcinoma, Serous - pathology | Young Adult | Cystadenoma, Serous - mortality | Neoplasm Grading | Adolescent | Aged, 80 and over | Cystadenocarcinoma, Serous - mortality | Denmark | Adult | Female | Aged | Neoplasm Staging | Cystadenoma, Serous - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Ovarian mucinous tumors associated with mature cystic teratomas: Morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary
by Vang, Russell and Gown, Allen M and Zhao, Chengquan and Barry, Todd S and Isacson, Christina and Richardson, Mary S and Ronnett, Brigitte M
American Journal of Surgical Pathology, ISSN 0147-5185, 06/2007, Volume 31, Issue 6, pp. 854 - 869
Most primary ovarian mucinous tumors are of surface epithelial-stromal origin and exhibit diffuse expression of cytokeratin 7 (CK7) combined with variable... 
Immunohistochemistry | Mucinous tumor | Ovary | Teratoma | SURGERY | CYTOKERATIN-7 | CDX2 | COORDINATE EXPRESSION | INTESTINAL-TYPE | mucinous tumor | PATHOLOGY | EPITHELIAL NEOPLASMS | ovary | PSEUDOMYXOMA-PERITONEI | DERMOID CYST | SQUAMOUS-CELL CARCINOMA | COLORECTAL ADENOCARCINOMA | immunohistochemistry | teratoma | METASTATIC CARCINOMAS | Diagnosis, Differential | Neoplasms, Multiple Primary - metabolism | Adenocarcinoma, Mucinous - pathology | Homeodomain Proteins - metabolism | Humans | Ovarian Neoplasms - pathology | Adenocarcinoma, Mucinous - secondary | Neoplasms, Multiple Primary - pathology | Biomarkers, Tumor | Teratoma - metabolism | Gastrointestinal Neoplasms - pathology | Teratoma - pathology | Keratin-7 - metabolism | Adenocarcinoma, Mucinous - metabolism | Female | Microfilament Proteins - metabolism | Ovarian Neoplasms - metabolism | Keratin-20 - metabolism | CDX2 Transcription Factor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights